TMDX - CIK 0001756262
TransMedics Group, Inc. (TMDX) reported revenue of $605.49M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2025 | $605.49M | +37.1% |
| FY 2024 | $441.54M | +82.7% |
| FY 2023 | $241.62M | +158.5% |
| FY 2022 | $93.46M | +208.8% |
| FY 2021 | $30.26M | +18.0% |
| FY 2020 | $25.64M | +8.6% |
| FY 2019 | $23.60M | +81.3% |
| FY 2018 | $13.02M | - |
TransMedics Group, Inc. (TMDX) reported revenue of $605.49M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2018 and fiscal 2025, TransMedics Group, Inc.'s revenue grew from $13.02M to $605.49M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.